Upjohn plans to produce an anti-baldness drug.
The Kalamazoo, Mich.-based drug company said it is investing $23 million in a manufacturing facility for Minoxidil, a drug that it believes could cure male pattern baldness--the type of hair loss that many men experience with advancing age--and patchy baldness--a massive loss of hair all over the body. The drug, which Upjohn first developed as a treatment for high blood pressure, is in the final stages of testing on human volunteers.
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
